Unlocking New Approaches to Urolithiasis Management Via Nutraceuticals


Cite item

Full Text

Abstract

Urolithiasis, commonly known as kidney stones, is characterized by the formation of hard deposits in the urinary tract. These stones can cause severe pain and discomfort, and their management typically involves a combination of medical interventions and lifestyle modifications. According to the literature, 30% and 50% of urolithiasis cases recur. Between 9 and 12% of persons in industrialised countries are predicted to have urolithiasis at some time. Due to the high frequency of stone formation, recurrent nature, and prevalence in adults, it has a significant impact on society, the person, and the health care system. Adopting the best prophylactic measures is crucial in light of these developments to decrease the impact of urolithiasis on individuals and society. In recent years, there has been growing interest in the potential role of nutraceuticals in the management of urolithiasis. Nutraceuticals, such as herbal extracts, vitamins, minerals, and probiotics, have gained recognition for their potential in promoting urinary health and reducing the risk of urolithiasis. These compounds can aid in various ways, including inhibiting crystal formation, enhancing urine pH balance, reducing urinary calcium excretion, and supporting kidney function. Additionally, nutraceuticals can help alleviate symptoms associated with urolithiasis, such as pain and inflammation. While medical interventions remain crucial, incorporating nutraceuticals into a comprehensive management plan can offer a holistic approach to urolithiasis, improving patient outcomes and quality of life. Therefore, nutraceuticals may be a desirable choice for treating and avoiding recurring urolithiasis for patients and medical professionals. Therefore, the present study has focused on nutraceuticals' role in preventing urolithiasis.

About the authors

Ravindra Singh

Department of Pharmacy, NIMS Institute of Pharmacy, NIMS University Rajasthan

Email: info@benthamscience.net

Anurag Mishra

Department of Pharmacy, NIMS Institute of Pharmacy, NIMS University Rajasthan

Author for correspondence.
Email: info@benthamscience.net

Shailendra Chandel

Department of Pharmacy, NIMS Institute of Pharmacy, NIMS University Rajasthan

Email: info@benthamscience.net

Mohit Agarwal

Department of Pharmacy, NIMS Institute of Pharmacy, NIMS University Rajasthan

Email: info@benthamscience.net

Himmat Chawra

Department of Pharmacy, NIMS Institute of Pharmacy, NIMS University Rajasthan

Email: info@benthamscience.net

Mithilesh Singh

Department of Pharmacy, NIMS Institute of Pharmacy, NIMS University Rajasthan

Email: info@benthamscience.net

Gaurav Dubey

Department of Pharmacy, NIMS Institute of Pharmacy, NIMS University Rajasthan

Email: info@benthamscience.net

References

  1. Ahmad, M.; Butt, M.A.; Zhang, G.; Sultana, S.; Tariq, A.; Zafar, M. Bergenia ciliata: A comprehensive review of its traditional uses, phytochemistry, pharmacology and safety. Biomed. Pharmacother., 2018, 97, 708-721.
  2. Lieske, J.C.; Walsh-Reitz, M.M.; Toback, F.G. Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation. Am. J. Physiol., 1992, 262(4 Pt 2), F622-F630. PMID: 1566875
  3. Ahmad, M.; Shaheen, G.; Ahmad, S.; Akram, M.; Shah, S.M.A.; Zakki, S.A. Clinical efficacy of Unani medicine Renax for treatment of Urolithiasis. Pak. J. Pharm. Sci., 2017, 30(S5), 2003-2006. PMID: 29105635
  4. Ahmed, S.; Hasan, M.M.; Khan, H.; Mahmood, Z.A.; Patel, S. The mechanistic insight of polyphenols in calcium oxalate urolithiasis mitigation. Biomed. Pharmacother., 2018, 106(2018), 1292-1299.
  5. Kataria, R.; Khatkar, A. Molecular docking of natural phenolic compounds for the screening of urease inhibitors. Curr. Pharm. Biotechnol., 2019, 20(5), 410-421. doi: 10.2174/1389201020666190409110948 PMID: 30963969
  6. Akram, M.; Idrees, M. Progress and prospects in the management of kidney stones and developments in phyto-therapeutic modalities. Int. J. Immunopathol. Pharmacol., 2019, 33 doi: 10.1177/2058738419848220 PMID: 31046493
  7. Garg, S.; Roy, A. A current perspective of plants as an antibacterial agent: a review. Curr. Pharm. Biotechnol., 2020, 21(15), 1588-1602. doi: 10.2174/1389201021666200622121249 PMID: 32568018
  8. Akter, S.; Netzel, M.; Tinggi, U.; Fletcher, M.; Osborne, S.; Sultanbawa, Y. Interactions between phytochemicals and minerals in terminalia ferdinandiana and implications for mineral bioavailability. Front. Nutr., 2020, 7, 598219. doi: 10.3389/fnut.2020.598219 PMID: 33425972
  9. Chen, X.; Shen, L.; Gu, X.; Dai, X.; Zhang, L.; Xu, Y.; Zhou, P. High-dose supplementation with vitamin C--induced pediatric urolithiasis: The first case report in a child and literature review. Urology., 2014, 84(4), 922-924. doi: 10.1016/j.urology.2014.07.021 PMID: 25260453
  10. Chewcharat, A.; Thongprayoon, C.; Vaughan, L.E.; Mehta, R.A.; Schulte, P.J.; O’Connor, H.M.; Lieske, J.C.; Taylor, E.N.; Rule, A.D. Dietary risk factors for incident and recurrent symptomatic kidney stones. Mayo Clin. Proc., 2022, 97(8), 1437-1448. doi: 10.1016/j.mayocp.2022.04.016 PMID: 35933132
  11. Daly, R.M.; Ebeling, P.R. Is excess calcium harmful to health? Nutrients., 2010, 2(5), 505-522. doi: 10.3390/nu2050505 PMID: 22254038
  12. Della Guardia, L.; Roggi, C.; Cena, H. Diet-induced acidosis and alkali supplementation. Int. J. Food Sci. Nutr., 2016, 67(7), 754-761. doi: 10.1080/09637486.2016.1198889 PMID: 27338594
  13. Dissayabutra, T.; Kalpongnukul, N.; Chindaphan, K.; Srisa-art, M.; Ungjaroenwathana, W.; Kaewwongse, M.; Iampenkhae, K.; Tosukhowong, P. Urinary sulfated glycosaminoglycan insufficiency and chondroitin sulfate supplement in urolithiasis. PLoS One, 2019, 14(3), e0213180. doi: 10.1371/journal.pone.0213180 PMID: 30845174
  14. Eynard, A.R.; Navarro, A. Crosstalk among dietary polyunsaturated fatty acids, urolithiasis, chronic inflammation, and urinary tract tumor risk. Nutrition, 2013, 29(7-8), 930-938. doi: 10.1016/j.nut.2012.12.014 PMID: 23594581
  15. Ferraro, P.M.; Curhan, G.C.; Gambaro, G.; Taylor, E.N. Total, dietary, and supplemental vitamin C intake and risk of incident kidney stones. Am. J. Kidney Dis., 2016, 67(3), 400-407. doi: 10.1053/j.ajkd.2015.09.005 PMID: 26463139
  16. Barghouthy, Y.; Somani, B.K. Role of citrus fruit juices in prevention of kidney stone disease (KSD): A narrative review. Nutrients., 2021, 13(11), 4117. doi: 10.3390/nu13114117 PMID: 34836376
  17. Baldini, N.; Torreggiani, E.; Roncuzzi, L.; Perut, F.; Zini, N.; Avnet, S. Exosome-like nanovesicles isolated from Citrus limon L. exert anti-oxidative effect. Curr. Pharm. Biotechnol., 2018, 19(11), 877-885. doi: 10.2174/1389201019666181017115755 PMID: 30332948
  18. Ben Saad, A.; Tiss, M.; Keskes, H.; Chaari, A.; Sakavitsi, M.E.; Hamden, K.; Halabalaki, M.; Allouche, N. Antihyperlipidemic, antihyperglycemic, and liver function protection of Olea europaea var. meski stone and seed extracts: Lc-esi-hrms-based composition analysis. J. Diabetes Res., 2021, 2021, 1-10. doi: 10.1155/2021/6659415 PMID: 33816636
  19. Borin, J.F.; Knight, J.; Holmes, R.P.; Joshi, S.; Goldfarb, D.S.; Loeb, S. Plant-based milk alternatives and risk factors for kidney stones and chronic kidney disease. J Ren Nutr., 2022, 32(2022), 363-365.
  20. Gupta, G.; Dahiya, R.; Singh, Y.; Mishra, A.; Verma, A.; Gothwal, S.K.; Aljabali, A.A.A.; Dureja, H.; Prasher, P.; Negi, P.; Kapoor, D.N.; Goyal, R.; Tambuwala, M.M.; Chellappan, D.K.; Dua, K. Monotherapy of RAAS blockers and mobilization of aldosterone: A mechanistic perspective study in kidney disease. Chem. Biol. Interact., 2020, 317, 108975. doi: 10.1016/j.cbi.2020.108975 PMID: 32032593
  21. Cai, T.; Tiscione, D.; Puglisi, M.; Malossini, G.; Ruggera, L.; Verze, P.; Arcaniolo, D.; Palmieri, A. Phyllanthus niruri and Chrysanthellum americanum in association with potassium and magnesium citrates are able to prevent symptomatic episode in patients affected by recurrent urinary stones: A prospective study. Arch. Ital. Urol. Androl., 2021, 93(2), 184-188.
  22. Gupta, G.; Chellappan, D.K.; Kikuchi, I.S.; Pinto, T.J.A.; Pabreja, K.; Agrawal, M.; Singh, Y.; Tiwari, J.; Dua, K. Nephrotoxicity in rats exposed to paracetamol: The protective role of moralbosteroid, a steroidal glycoside. J. Environ. Pathol. Toxicol. Oncol., 2017, 36(2), 113-119. doi: 10.1615/JEnvironPatholToxicolOncol.2017019457 PMID: 29199592
  23. Chen, Y.; Ye, L.; Li, W.; Li, D.; Li, F. Hyperoside protects human kidney-2 cells against oxidative damage induced by oxalic acid. Mol. Med. Rep., 2018, 18(1), 486-494. doi: 10.3892/mmr.2018.8948 PMID: 29750296
  24. Chen, Y.; Zhang, H.; Fan, W.; Mats, L.; Liu, R.; Deng, Z.; Tsao, R. Anti-Inflammatory Effect and Cellular Transport Mechanism of Phenolics from Common Bean (Phaseolus vulga L.) Milk and Yogurts in Caco-2 Mono- and Caco-2/EA.hy926 Co-Culture Models. J. Agric. Food Chem., 2021, 69(5), 1513-1523. doi: 10.1021/acs.jafc.0c06934 PMID: 33497227
  25. Daniel, S.L.; Moradi, L.; Paiste, H.; Wood, K.D.; Assimos, D.G.; Holmes, R.P.; Nazzal, L.; Hatch, M.; Knight, J. Forty years of oxalobacter formigenes, a gutsy oxalate-degrading specialist. Appl. Environ. Microbiol., 2021, 87(18), e00544-e21. doi: 10.1128/AEM.00544-21 PMID: 34190610
  26. Das, P.; Gupta, G.; Velu, V.; Awasthi, R.; Dua, K.; Malipeddi, H. Formation of struvite urinary stones and approaches towards the inhibition-A review. Biomed. Pharmacother., 2017, 96(2017), 361-370.
  27. Das, P.; Kumar, K.; Nambiraj, A.; Rajan, R.; Awasthi, R.; Dua, K.; M, H. Potential therapeutic activity of Phlogacanthus thyrsiformis Hardow (Mabb) flower extract and its biofabricated silver nanoparticles against chemically induced urolithiasis in male Wistar rats. Int. J. Biol. Macromol., 2017, 103, 621-629. doi: 10.1016/j.ijbiomac.2017.05.096 PMID: 28528955
  28. De Bellis, R.; Piacentini, M.P.; Meli, M.A.; Mattioli, M.; Menotta, M.; Mari, M.; Valentini, L.; Palomba, L.; Desideri, D.; Chiarantini, L. In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: Analysis of a potential antilithiatic mechanism. PLoS. One., 2019, 14(6), e0218734. doi: 10.1371/journal.pone.0218734 PMID: 31238335
  29. Dinnimath, B.M.; Jalalpure, S.S.; Patil, U.K. Antiurolithiatic activity of natural constituents isolated from Aerva lanata. J. Ayurveda Integr. Med., 2017, 8(4), 226-232. doi: 10.1016/j.jaim.2016.11.006 PMID: 29169771
  30. Divya, G.; Albert, A.; Singab, A.N.B.; Ayoub, I.M.; Al-Sayed, E.; Paul, E.; Manoharan, K.; Saso, L.; Selvam, G.S. Renoprotective effect of tectorigenin glycosides isolated from Iris spuria L. (Zeal) against hyperoxaluria and hyperglycemia in NRK-49Fcells. Nat. Prod. Res., 2021, 35(6), 1029-1034. doi: 10.1080/14786419.2019.1613396 PMID: 31135219
  31. Emiliani, E.; Jara, A.; Kanashiro, A.K. Phytotherapy and herbal medicines for kidney stones. Curr. Drug Targets, 2020, 22(1), 22-30. doi: 10.2174/1389450121666200929115555 PMID: 32990535
  32. Fan, Q.X.; Gong, S.Q.; Hong, X.Z.; Feng, X.M.; Zhang, F.J. Clinical-grade Garcinia cambogia extract dissolves calcium oxalate crystals in Drosophila kidney stone models. Eur. Rev. Med. Pharmacol. Sci., 2020, 24(11), 6434-6445. PMID: 32572941
  33. Harvey, N.C.; Biver, E.; Kaufman, J.M.; Bauer, J.; Branco, J.; Brandi, M.L.; Bruyère, O.; Coxam, V.; Cruz-Jentoft, A.; Czerwinski, E.; Dimai, H.; Fardellone, P.; Landi, F.; Reginster, J.Y.; Dawson-Hughes, B.; Kanis, J.A.; Rizzoli, R.; Cooper, C. The role of calcium supplementation in healthy musculoskeletal ageing: An expert consensus meeting of the european society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO) and the International Foundation for Osteoporosis (IOF). Osteoporos. Int., 2017, 28(2017), 447-462.
  34. Fayez Hass, N.; Khaled Ibr, M.; Yousef El, S.; Abd Allah, H. Characterization of biofilm producer nanobacteria isolated from kidney stones of some egyptian patients. Pak. J. Biol. Sci., 2021, 24(9), 953-970. doi: 10.3923/pjbs.2021.953.970 PMID: 34585548
  35. Gautam, M.; Datt, N.; Chahota, R.K. Assessment of calcium oxalate crystal inhibition potential, antioxidant activity and amino acid profiling in horse gram (Macrotyloma uniflorum): High altitude farmer's varieties. 3 Biotech., 2020, 10(2020), 402.
  36. Ghali, F.; Dagrosa, L.M.; Moses, R.A.; Ursiny, M.; Eisner, B.H.; Jr, V.M.P. Changing incidence of factitious renal stone disease. Clin. Nephrol., 2018, 90(2), 102-105. doi: 10.5414/CN109331 PMID: 29882511
  37. Gohain, A.; Sharma, A.; Gogoi, H.J.; Cooper, R.; Kaur, R.; Nayik, G.A.; Shaikh, A.M.; Kovács, B.; Areche, F.O.; Ansari, M.J.; Alabdallah, N.M.; Al-Farga, A. Bergenia pacumbis (Buch.-Ham. ex D.Don) C.Y.Wu & J.T.Pan: A comprehensive review on traditional uses, phytochemistry and pharmacology; Plants: Basel, Switzerland, 2022, p. 11.
  38. Shahcheraghi, S.H.; Aljabali, A.A.A.; Al Zoubi, M.S.; Mishra, V.; Charbe, N.B.; Haggag, Y.A.; Shrivastava, G.; Almutary, A.G.; Alnuqaydan, A.M.; Barh, D.; Dua, K.; Chellappan, D.K.; Gupta, G.; Lotfi, M.; Serrano-Aroca, Á.; Bahar, B.; Mishra, Y.K.; Takayama, K.; Panda, P.K.; Bakshi, H.A.; Tambuwala, M.M. Overview of key molecular and pharmacological targets for diabetes and associated diseases. Life. Sci., 2021, 278, 119632. doi: 10.1016/j.lfs.2021.119632 PMID: 34019900
  39. Gupta, M.; Bhayana, S.; Sikka, S. Role of urinary inhibitors and promoters in calcium oxalate crystallisation. Int. J. Res. Pharm. Sci., 2011, 1(4)
  40. Haghighatdoost, F.; Sadeghian, R.; Abbasi, B. The associations between tea and coffee drinking and risk of calcium-oxalate renal stones. Plant Foods Hum. Nutr., 2021, 76(4), 516-522. doi: 10.1007/s11130-021-00933-4 PMID: 34735676
  41. Horby, P.; Lim, W.S.; Emberson, J.R.; Mafham, M.; Bell, J.L.; Linsell, L.; Staplin, N.; Brightling, C.; Ustianowski, A.; Elmahi, E.; Prudon, B.; Green, C.; Felton, T.; Chadwick, D.; Rege, K.; Fegan, C.; Chappell, L.C.; Faust, S.N.; Jaki, T.; Jeffery, K.; Montgomery, A.; Rowan, K.; Juszczak, E.; Baillie, J.K.; Haynes, R.; Landray, M.J. Dexamethasone in hospitalized patients with Covid-19. N. Engl. J. Med., 2021, 384(8), 693-704. doi: 10.1056/NEJMoa2021436 PMID: 32678530
  42. Horby, P.; Mafham, M.; Linsell, L.; Bell, J.L.; Staplin, N.; Emberson, J.R.; Wiselka, M.; Ustianowski, A.; Elmahi, E.; Prudon, B.; Whitehouse, T.; Felton, T.; Williams, J.; Faccenda, J.; Underwood, J.; Baillie, J.K.; Chappell, L.C.; Faust, S.N.; Jaki, T.; Jeffery, K.; Lim, W.S.; Montgomery, A.; Rowan, K.; Tarning, J.; Watson, J.A.; White, N.J.; Juszczak, E.; Haynes, R.; Landray, M.J. Effect of hydroxychloroquine in hospitalized patients with covid-19. N. Engl. J. Med., 2020, 383(21), 2030-2040. doi: 10.1056/NEJMoa2022926 PMID: 33031652
  43. Hosseini, A.; Mirzaee, F.; Davoodi, A.; Bakhshi, J.H.; Azadbakh, M. The traditional medicine aspects, biological activity and phytochemistry of Arnebia spp. Med. Glas., 2018, 15, 1-9.
  44. Jiang, K.; Tang, K.; Liu, H.; Xu, H.; Ye, Z.; Chen, Z. Ascorbic acid supplements and kidney stones incidence among men and women: A systematic review and meta-analysis. Urol. J., 2019, 16(2), 115-120. PMID: 30178451
  45. Johnson, K.C.; Pittas, A.G.; Margolis, K.L.; Peters, A.L.; Phillips, L.S.; Vickery, E.M.; Nelson, J.; Sheehan, P.R.; Reboussin, D.; Malozowski, S.; Chatterjee, R.; Pittas, A.G.; Brodsky, I.; Ceglia, L.; Chadha, C.; Chatterjee, R.; Dawson-Hughes, B.; Desouza, C.; Dolor, R.; Foreyt, J.; Ghazi, A.; Hsia, D.S.; Johnson, K.C.; Kashyap, S.R.; Kim, S.; LeBlanc, E.S.; Lewis, M.R.; Liao, E.; Malozowski, S.; Neff, L.M.; O’Neil, P.; Park, J.; Peters, A.; Phillips, L.S.; Pratley, R.; Raskin, P.; Rasouli, N.; Robbins, D.; Rosen, C.; Aroda, V.R.; Sheehan, P.; Staten, M.A.; Ware, J.H.; Knowler, W.C. Safety and tolerability of high-dose daily vitamin D3 supplementation in the vitamin D and type 2 diabetes (D2d) study—a randomized trial in persons with prediabetes. Eur. J. Clin. Nutr., 2022, 76(8), 1117-1124. doi: 10.1038/s41430-022-01068-8 PMID: 35140313
  46. Kahwati, L.C.; Weber, R.P.; Pan, H.; Gourlay, M.; LeBlanc, E.; Coker-Schwimmer, M.; Viswanathan, M.; Vitamin, D. Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults. JAMA., 2018, 319(15), 1600-1612. doi: 10.1001/jama.2017.21640 PMID: 29677308
  47. Huang, F.; Sun, X.Y.; Ouyang, J.M. Preparation and characterization of selenized Astragalus polysaccharide and its inhibitory effect on kidney stones. Mater. Sci. Eng. C, 2020, 110, 110732. doi: 10.1016/j.msec.2020.110732 PMID: 32204043
  48. Huang, J.L.; Mo, Z.Y.; Li, Z.Y.; Liang, G.Y.; Liu, H.L.; Aschner, M.; Ou, S.Y.; Zhou, B.; Chen, Z.M.; Jiang, Y.M. Association of lead and cadmium exposure with kidney stone incidence: A study on the non-occupational population in Nandan of China. J. Trace Elem. Med. Biol., 2021, 68, 126852.
  49. Pattanayak, P.; Singh, S.K.; Gulati, M.; Vishwas, S.; Kapoor, B.; Chellappan, D.K.; Anand, K.; Gupta, G.; Jha, N.K.; Gupta, P.K.; Prasher, P.; Dua, K.; Dureja, H.; Kumar, D.; Kumar, V. Microfluidic chips: Recent advances, critical strategies in design, applications and future perspectives. Microfluid. Nanofluidics, 2021, 25(12), 99. doi: 10.1007/s10404-021-02502-2 PMID: 34720789
  50. Karam, A.; Mjaess, G.; Younes, H.; Aoun, F. Increase in urolithiasis prevalence due to vitamins C and D supplementation during the COVID-19 pandemic. J. Public Health., 2022, 44(4), e625-e626. doi: 10.1093/pubmed/fdab328 PMID: 34486059
  51. Kim, D.; Rimer, J.D.; Asplin, J.R. Hydroxycitrate: A potential new therapy for calcium urolithiasis. Urolithiasis, 2019, 47(4), 311-320. doi: 10.1007/s00240-019-01125-1 PMID: 30915494
  52. Kozyrakis, D.; Paridis, D.; Karatzas, A.; Soukias, G.; Dailiana, Z. Do calcium supplements predispose to urolithiasis? Curr. Urol. Rep., 2017, 18(3), 17. doi: 10.1007/s11934-017-0668-9 PMID: 28233226
  53. Leaf, D.E. Calcium kidney stones. N. Engl. J. Med., 2010, 363(25), 2470-2471. doi: 10.1056/NEJMc1011349 PMID: 21158674
  54. Letavernier, E.; Daudon, M.; Vitamin, D. Vitamin D, hypercalciuria and kidney stones. Nutrients, 2018, 10(3), 366. doi: 10.3390/nu10030366 PMID: 29562593
  55. Levenson, D.I.; Bockman, R.S. A review of calcium preparations. Nutr. Rev., 1994, 52(7), 221-232. doi: 10.1111/j.1753-4887.1994.tb01427.x PMID: 8090373
  56. Mocanu, C.A.; Simionescu, T.P.; Mocanu, A.E.; Garneata, L. Plant-based versus animal-based low protein diets in the management of chronic kidney disease. Nutrients., 2021, 13(11), 3721.
  57. Attalla, K.; De, S.; Sarkissian, C.; Monga, M. Seasonal variations in urinary calcium, volume, and vitamin d in kidney stone formers. Int. Braz. J. Urol., 2018, 44, 947-951.
  58. Bargagli, M.; Ferraro, P.M.; Vittori, M.; Lombardi, G.; Gambaro, G.; Somani, B. Calcium and vitamin D supplementation and their association with kidney stone disease: A narrative review. Nutrients., 2021, 13(12), 4363. doi: 10.3390/nu13124363 PMID: 34959915
  59. Gupta, G.; de Jesus Andreoli Pinto, T.; Chellappan, D.K.; Mishra, A.; Malipeddi, H.; Dua, K. A clinical update on metformin and lung cancer in diabetic patients. Panminerva Med., 2018, 60(2), 70-75. doi: 10.23736/S0031-0808.18.03394-3 PMID: 29370676
  60. Brogan, M.; Astor, B.C.; Melamed, M.L. Vitamin D in chronic kidney disease. Curr. Opin. Nephrol. Hypertens., 2020, 29(2), 243-247. doi: 10.1097/MNH.0000000000000591 PMID: 31996592
  61. Eskandarifar, A.; Roshani, D.; Tabarkhun, A.; Ataee, E. Assessment of serum level of vitamin D in infants with nephrolithiasis. Iran. J. Kidney Dis., 2021, 1(2), 116-120. PMID: 33764322
  62. Gillion, V.; Saussez, T.P.; Van Nieuwenhove, S.; Jadoul, M. Extremely rapid stone formation in cystinuria: Look out for dietary supplements! Clin. Kidney J., 2021, 14(6), 1694-1696. doi: 10.1093/ckj/sfab013 PMID: 34084466
  63. Guerra, A.; Ticinesi, A.; Allegri, F.; Nouvenne, A.; Prati, B.; Pinelli, S.; Merli, R.; Tana, C.; Lauretani, F.; Aloe, R.; Borghi, L.; Meschi, T. Insights about urinary hippuric and citric acid as biomarkers of fruit and vegetable intake in patients with kidney stones: The role of age and sex. Nutrition., 2019, 59, 83-89. doi: 10.1016/j.nut.2018.07.112 PMID: 30471528
  64. Guzel, A.; Yunusoglu, S.; Calapoglu, M.; Candan, I.A.; Onaran, I.; Oncu, M.; Ergun, O.; Oksay, T. Protective effects of quercetin on oxidative stress-induced tubular epithelial damage in the experimental rat hyperoxaluria model. Medicina., 2021, 57(6), 566. doi: 10.3390/medicina57060566 PMID: 34204866
  65. Kanlaya, R.; Thongboonkerd, V. Protective effects of epigallocatechin-3-gallate from green tea in various kidney diseases. Adv. Nutr., 2019, 10(1), 112-121.
  66. Li, S.; Macaringue, E.G.J.; Zhou, D.; Shi, P.; Tang, W.; Gong, J. Discovering inhibitor molecules for pathological crystallization of CaOx kidney stones from natural extracts of medical herbs. J. Ethnopharmacol., 2022, 284, 114733. doi: 10.1016/j.jep.2021.114733 PMID: 34644589
  67. Li, Z.; Chang, L.; Ren, X.; Hu, Y.; Chen, Z. Modulation of rat kidney stone crystallization and the relative oxidative stress pathway by green tea polyphenol. ACS Omega., 2021, 6(2), 1725-1731. doi: 10.1021/acsomega.0c05903 PMID: 33490831
  68. Rode, J.; Bazin, D.; Dessombz, A.; Benzerara, Y.; Letavernier, E.; Tabibzadeh, N.; Hoznek, A.; Tligui, M.; Traxer, O.; Daudon, M.; Haymann, J.P. Daily green tea infusions in hypercalciuric renal stone patients: No evidence for increased stone risk factors or oxalate-dependent stones. Nutrients., 2019, 11(2), 256. doi: 10.3390/nu11020256 PMID: 30678344
  69. Yasir, F.; Wahab, A.; Choudhary, M.I. Protective effect of dietary polyphenol caffeic acid on ethylene glycol-induced kidney stones in rats. Urolithiasis., 2018, 46(2), 157-166. doi: 10.1007/s00240-017-0982-1 PMID: 28616648
  70. Ye, Q.L.; Wang, D.M.; Wang, X.; Zhang, Z.Q.; Tian, Q.X.; Feng, S.Y.; Zhang, Z.H.; Yu, D.X.; Ding, D.M.; Xie, D.D. Sirt1 inhibits kidney stones formation by attenuating calcium oxalate-induced cell injury. Chem. Biol. Interact., 2021, 347, 109605. doi: 10.1016/j.cbi.2021.109605 PMID: 34333021
  71. Zeng, X.; Xi, Y.; Jiang, W. Protective roles of flavonoids and flavonoid-rich plant extracts against urolithiasis: A review. Crit. Rev. Food Sci. Nutr., 2019, 59(13), 2125-2135. doi: 10.1080/10408398.2018.1439880 PMID: 29432040
  72. Lewandowski, S.; Rodgers, A.L. Idiopathic calcium oxalate urolithiasis: Risk factors and conservative treatment. Clin. Chim. Acta., 2004, 345(1-2), 17-34.
  73. Li, K.; Wang, X.F.; Li, D.Y.; Chen, Y.C.; Zhao, L.J.; Liu, X.G.; Guo, Y.F.; Shen, J.; Lin, X.; Deng, J.; Zhou, R.; Deng, H.W. The good, the bad, and the ugly of calcium supplementation: A review of calcium intake on human health. Clin. Interv. Aging, 2018, 13, 2443-2452. doi: 10.2147/CIA.S157523 PMID: 30568435
  74. Lin, B.B.; Lin, M.E.; Huang, R.H.; Hong, Y.K.; Lin, B.L.; He, X.J. Dietary and lifestyle factors for primary prevention of nephrolithiasis: A systematic review and meta-analysis. BMC Nephrol., 2020, 21(1), 267. doi: 10.1186/s12882-020-01925-3 PMID: 32652950
  75. Madden, E.; McLachlan, C.; Oketch-Rabah, H.; Calderón, A.I. Safety of cranberry: Evaluation of evidence of kidney stone formation and botanical drug-interactions. Planta Med., 2021, 87(10/11), 803-817. doi: 10.1055/a-1497-6241 PMID: 34015833
  76. Massey, L. Magnesium therapy for nephrolithiasis. Magnes. Res., 2005, 18(2), 123-126. PMID: 16100850
  77. Mehta, M.; Goldfarb, D.S.; Nazzal, L. The role of the microbiome in kidney stone formation. Int. J. Surg., 2016, 36(Pt D), 607-612. doi: 10.1016/j.ijsu.2016.11.024 PMID: 27847292
  78. Messa, P.; Castellano, G.; Vettoretti, S.; Alfieri, C.M.; Giannese, D.; Panichi, V.; Cupisti, A. Vitamin D and calcium supplementation and urolithiasis: A controversial and multifaceted relationship. Nutrients., 2023, 15(7), 1724. doi: 10.3390/nu15071724 PMID: 37049567
  79. Negri, A.L. The role of zinc in urinary stone disease. Int. Urol. Nephrol., 2018, 50(5), 879-883. doi: 10.1007/s11255-017-1784-7 PMID: 29344880
  80. Nirumand, M.; Hajialyani, M.; Rahimi, R.; Farzaei, M.; Zingue, S.; Nabavi, S.; Bishayee, A. Dietary plants for the prevention and management of kidney stones: Preclinical and clinical evidence and molecular mechanisms. Int. J. Mol. Sci., 2018, 19(3), 765. doi: 10.3390/ijms19030765 PMID: 29518971
  81. Oswal, M.; Varghese, R.; Zagade, T.; Dhatrak, C.; Sharma, R.; Kumar, D. Dietary supplements and medicinal plants in urolithiasis: diet, prevention, and cure. J. Pharm. Pharmacol., 2023, 75(6), 719-745. doi: 10.1093/jpp/rgac092 PMID: 37130140
  82. Palermo, A.; Naciu, A.M.; Tabacco, G.; Manfrini, S.; Trimboli, P.; Vescini, F.; Falchetti, A. Calcium citrate: From biochemistry and physiology to clinical applications. Rev. Endocr. Metab. Disord., 2019, 20(3), 353-364. doi: 10.1007/s11154-019-09520-0 PMID: 31643038
  83. Peerapen, P.; Thongboonkerd, V. Kidney stone prevention. Adv. Nutr., 2023, 14, 555-569.
  84. Preminger, G.M. Oxaluria--the neglected stepchild of nephrolithiasis? J. Urol., 2003, 170(2), 402-403. doi: 10.1097/01.ju.0000077445.02082.3d PMID: 12853785
  85. Prentice, R.L.; Pettinger, M.B.; Jackson, R.D.; Wactawski-Wende, J.; Lacroix, A.Z.; Anderson, G.L.; Chlebowski, R.T.; Manson, J.E.; Van Horn, L.; Vitolins, M.Z.; Datta, M.; LeBlanc, E.S.; Cauley, J.A.; Rossouw, J.E. Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos. Int., 2013, 24, 567-580.
  86. Prezioso, D.; Strazzullo, P.; Lotti, T.; Bianchi, G.; Borghi, L.; Caione, P.; Carini, M.; Caudarella, R.; Ferraro, M.; Gambaro, G.; Gelosa, M.; Guttilla, A.; Illiano, E.; Martino, M.; Meschi, T.; Messa, P.; Miano, R.; Napodano, G.; Nouvenne, A.; Rendina, D.; Rocco, F.; Rosa, M.; Sanseverino, R.; Salerno, A.; Spatafora, S.; Tasca, A.; Ticinesi, A.; Travaglini, F.; Trinchieri, A.; Vespasiani, G.; Zattoni, F. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Arch. Ital. Urol. Androl., 2015, 87(2), 105-120.
  87. Prochaska, M. Bisphosphonates and management of kidney stones and bone disease. Curr. Opin. Nephrol. Hypertens., 2021, 30(2), 184-189. doi: 10.1097/MNH.0000000000000682 PMID: 33394731
  88. Ambrogi, V.; Bottacini, F.; O’Callaghan, J.; Casey, E.; van Breen, J.; Schoemaker, B.; Cao, L.; Kuipers, B.; O’Connell Motherway, M.; Schoterman, M.; van Sinderen, D. Infant-associated bifidobacterial β-galactosidases and their ability to synthesize galacto-oligosaccharides. Front. Microbiol., 2021, 12, 662959. doi: 10.3389/fmicb.2021.662959 PMID: 34012427
  89. Borges, D.; Guzman-Novoa, E.; Goodwin, P.H. Effects of prebiotics and probiotics on honey bees (Apis mellifera) infected with the microsporidian parasite nosema ceranae. Microorganisms., 2021, 9(3), 481. doi: 10.3390/microorganisms9030481 PMID: 33668904
  90. Cao, A. The last secret of protein folding: the real relationship between long-range interactions and local structures. Protein J., 2020, 39(5), 422-433. doi: 10.1007/s10930-020-09925-w PMID: 33040262
  91. Chen, Y.; Wang, Q.; Gao, W.; Ma, B.; Xue, D.; Hao, C. Changes and correlations of the intestinal flora and liver metabolite profiles in mice with gallstones. Front. Physiol., 2021, 12, 716654. doi: 10.3389/fphys.2021.716654 PMID: 34489732
  92. Emami, N.K.; Dalloul, R.A. Centennial review: Recent developments in host-pathogen interactions during necrotic enteritis in poultry. Poult. Sci., 2021, 100(9), 101330. doi: 10.1016/j.psj.2021.101330 PMID: 34280643
  93. Yang, Y.; Ma, Y.; Hu, X.; Cui, S.W.; Zhang, T.; Miao, M. Reuteransucrase-catalytic kinetic modeling and functional characteristics for novel prebiotic gluco-oligomers. Food Funct., 2020, 11(8), 7037-7047. doi: 10.1039/D0FO00225A PMID: 32812985
  94. Gaylor, M.O.; Miro, P.; Vlaisavljevich, B.; Kondage, A.A.S.; Barge, L.M.; Omran, A.; Videau, P.; Swenson, V.A.; Leinen, L.J.; Fitch, N.W.; Cole, K.L.; Stone, C.; Drummond, S.M.; Rageth, K.; Dewitt, L.R.; González Henao, S.; Karanauskus, V. Plausible emergence and self assembly of a primitive phospholipid from reduced phosphorus on the primordial earth. Orig. Life Evol. Biosph., 2021, 51, 185-213.
  95. Stepanova, N.; Akulenko, I.; Serhiichuk, T.; Dovbynchuk, T.; Savchenko, S.; Tolstanova, G. Synbiotic supplementation and oxalate homeostasis in rats: focus on microbiota oxalate-degrading activity. Urolithiasis., 2022, 50(3), 249-258. doi: 10.1007/s00240-022-01312-7 PMID: 35129638
  96. Sumida, Y.; Yoneda, M.; Toyoda, H.; Yasuda, S.; Tada, T.; Hayashi, H.; Nishigaki, Y.; Suzuki, Y.; Naiki, T.; Morishita, A.; Tobita, H.; Sato, S.; Kawabe, N.; Fukunishi, S.; Ikegami, T.; Kessoku, T.; Ogawa, Y.; Honda, Y.; Nakahara, T.; Munekage, K.; Ochi, T.; Sawada, K.; Takahashi, A.; Arai, T.; Kogiso, T.; Kimoto, S.; Tomita, K.; Notsumata, K.; Nonaka, M.; Kawata, K.; Takami, T.; Kumada, T.; Tomita, E.; Okanoue, T.; Nakajima, A. Common drug pipelines for the treatment of diabetic nephropathy and hepatopathy: Can we kill two birds with one stone? Int. J. Mol. Sci., 2020, 21(14), 4939.
  97. Ke, A.; Parreira, V.R.; Farber, J.M.; Goodridge, L. Selection of a potential synbiotic against cronobacter sakazakii. J. Food Prot., 2022, 85(9), 1240-1248. doi: 10.4315/JFP-22-048 PMID: 35435968
  98. Klassen, S.S.; VanBlyderveen, W.; Eccles, L.; Kelly, P.G.; Borges, D.; Goodwin, P.H.; Petukhova, T.; Wang, Q.; Guzman-Novoa, E. Nosema ceranae infections in honey bees (apis mellifera) treated with pre/probiotics and impacts on colonies in the field. Vet. Sci., 2021, 8(6), 107. doi: 10.3390/vetsci8060107 PMID: 34200566
  99. Mithul, A.S.; Wichienchot, S.; Tsao, R.; Ramakrishnan, S.; Chakkaravarthi, S. Role of dietary polyphenols on gut microbiota, their metabolites and health benefits. Food Res Int., 2021, 142(2021), 110189.
  100. Pastorek, A.; Clark, V.H.J.; Yurchenko, S.N.; Ferus, M.; Civiš, S. New physical insights: Formamide discharge decomposition and the role of fragments in the formation of large biomolecules. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2022, 278, 121322. doi: 10.1016/j.saa.2022.121322 PMID: 35537261

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers